Genio - About the company
Genio is an unfunded company based in Tulsa (United States), founded in 2019 by Thomas E Milner. It operates as an AI-based disease diagnosis tool for healthcare professionals. Genio has not raised any funding yet. The company has 147 active competitors, including 44 funded and 10 that have exited. Its top competitors include companies like Scholar Rock, SamanTree Medical and Lucida Medical.
Company Details
AI-based disease diagnosis tool for healthcare professionals. The company has developed a device called precise that assists with medical diagnosis and analysis of cancerous tissues. It has features for characterization, surgical workflow, tissue analysis, and more.
- Website
- genio.io
- Email ID
- *****@genio.io
Key Metrics
Founded Year
2019
Location
Tulsa, United States
Stage
Unfunded
Ranked
102nd among 147 active competitors
Employee Count
2 as on Jul 01, 2024
Similar Companies
Sign up to download Genio's company profile
Genio's funding and investors
Genio has not raised any funding rounds yet.
Genio's founders and board of directors
Founder? Claim ProfileThe founders of Genio is Thomas E Milner.
Here are the details of Genio's key team members:
- Thomas E Milner: Co-Founder of Genio.
View details of Genio's Founder profiles and Board Members
Genio's employee count trend
Genio has 2 employees as of Jul 24. Here is Genio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Genio's Competitors and alternates
Top competitors of Genio include Scholar Rock, SamanTree Medical and Lucida Medical. Here is the list of Top 10 competitors of Genio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Scholar Rock 2012, Cambridge (United States), Public | Developer of Antibody-based drugs for the treatment of primary myopathies | $103M | 61/100 | |
2nd | SamanTree Medical 2014, Lausanne (Switzerland), Series C | Developer of digital microscopy system for high-resolution imaging of tissue | $57.5M | 58/100 | |
3rd | Lucida Medical 2019, Cambridge (United Kingdom), Series A | Developer of MRI-based cancer screening technology using artificial intelligence (AI) | $11.5M | 58/100 | |
4th | Developer of diagnostic tests using metabolomics and nuclear magnetic resonance spectroscopy | $26.8M | 55/100 | ||
5th | Developer of diagnostic instruments, reagents, and related software | - | - | 54/100 | |
6th | Perfint Healthcare 2005, Chennai (India), Series D | Developer of solutions for image-guided interventional procedures | $41.5M | 54/100 | |
7th | Ionpath 2014, Menlo Park (United States), Series B | Developer of an imaging platform for tissue biopsies | $18M | 53/100 | |
8th | Developer of therapy-assist CT system for minimally invasive interventions | $8.4M | 52/100 | ||
9th | Provider of an AI-enabled immunotherapy based tumor diagnostic platform | $38.2M | 52/100 | ||
10th | Developer of non-invasive devices for real-time biomarker analysis of blood and tissue | $2.21M | 51/100 | ||
102nd | Genio 2019, Tulsa (United States), Unfunded | AI-based disease diagnosis tool for healthcare professionals | - | - | 23/100 |
Looking for more details on Genio's competitors? Click here to see the top ones
Genio's Investments and acquisitions
Genio has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Genio
Explore our recently published companies
- Ocncap - 2021 founded, Unfunded company
- Imbued Strength - Unfunded company
- Imbue Solution - Southfield based, Unfunded company
- Tony88 - Unfunded company
- Imb Libros Medicos - Lima based, Unfunded company
- Ocicos - Colombia based, 2022 founded, Unfunded company
